Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from BDX

Do Wall Street Analysts Like Becton, Dickinson and Company Stock?

MedTech giant Becton, Dickinson and Company underperformed relative to the broader market over the past year, but Wall Street analysts remain upbeat about the stock’s potential.

Barchart

Becton, Dickinson and Company's Q1 2025 Earnings: What to Expect

MedTech giant Becton, Dickinson and Company is expected to unveil its first-quarter results in the upcoming month and analysts expect a notable double-digit growth in earnings.

Barchart

3 Healthcare Innovators Advancing Medical Technology

The healthcare industry is set for growth due to evolving healthcare demands and the rapid evolution of medical technologies. Hence, investors might consider investing in healthcare stocks, Becton, Dickinson and Co. (BDX), Zimmer Biomet Holdings (ZBH), and Embecta (EMBC). Read more….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Becton, Dickinson and Company Stock Underperforming the Dow?

Becton, Dickinson and Company have underperformed the Dow Jones Industrials Average over the past year, yet Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

3 MedTech Innovators Revolutionizing Patient Care

The medtech market is thriving, thanks to the increasing investments and surging demand for enhanced efficiency. Therefore, investors could benefit from these trends by investing in fundamentally solid medical device stocks Becton, Dickinson and Company (BDX), Medtronic (MDT), and Abbott Laboratories (ABT), which are revolutionizing patient care. Keep reading.

StockNews.com

Becton, Dickinson and Company Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Becton, Dickinson and Company’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Barchart

Becton, Dickinson and Company Earnings Preview: What to Expect

Becton, Dickinson and Company is poised to announce its fourth-quarter results next month, and analysts predict a double-digit growth in the company’s bottom-line figure.

Barchart

Read news from The Economist, FT, and more,
with one subscription

3 Dividend Kings To Buy and Hold in Your Forever Portfolio

These three companies are top choices for a dividend-growth portfolio.

Barchart

3 Medical Device Stocks to Buy for Consistent Growth

The medical devices industry is on the verge of an incoming boom, fueled by its growing demand and technological advancements. In this evolving landscape, investors could scoop up shares of robust medical device stocks Alcon (ALC), Becton, Dickinson (BDX), and Abbott (ABT) for solid gains. Read more….

StockNews.com

3 MedTech Stocks to Watch as Innovation in Healthcare Soars

MedTech is a promising market driven by rising disease prevalence, innovative healthcare solutions, and significant growth in digital health technologies. Thus, adding strong MedTech stocks like Becton, Dickinson (BDX), Abbott (ABT), and Medtronic (MDT) to your watchlist could be wise as innovation in healthcare accelerates. Read more….

StockNews.com

Is Becton, Dickinson, and Company Stock Underperforming the Nasdaq?

Becton, Dickinson, and Company have recently underperformed in the Nasdaq, but Wall Street analysts are optimistic about the stock’s prospects.

Barchart

3 Healthcare Innovators Transforming Patient Care

The healthcare industry's long-term growth is fueled by rising R&D initiatives and the adoption of cutting-edge technologies. Hence, it could be ideal to buy fundamentally solid medical device stocks Alcon (ALC), Becton, Dickinson and Company (BDX), and STERIS (STE) for potential returns. Keep reading.

StockNews.com

Are Wall Street Analysts Predicting Becton, Dickinson, and Company Stock Will Climb or Sink?

While Becton, Dickinson, and Company has failed to surpass the broader market over the past year, Wall Street analysts are highly bullish on the stock’s prospects.

Barchart

What to Expect From Becton, Dickinson and Company’s Next Quarterly Earnings Report

Becton, Dickinson and Company is all set to release its fiscal third-quarter earnings next month, and analysts expect a double-digit profit increase.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

3 Top-Rated Healthcare Stocks With 20% to 35% Upside Potential

Amid a broader market rotation out of Big Tech stocks, investors can consider these three top-rated healthcare stocks with double-digit upside potential.

Barchart

3 Most Undervalued Dividend Kings To Buy Right Now

Picking up undervalued dividend stocks rewards investors with income and potential capital appreciation.

Barchart

Is Becton, Dickinson and Company Stock Underperforming the S&P 500?

Becton, Dickinson and Company has lagged the S&P 500 recently, but analysts are optimistic about the stock’s prospects.

Barchart

3 Highest-Rated Dividend Kings To Buy and Hold Forever

Not all dividend kings are alike. These are the top-rated ones on the list of investors are buying.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

3 Undervalued Dividend Aristocrats Trading Just Above Their 52 Week Lows

Now is a perfect opportunity to pick up these quality companies trading around their 52-week lows - before they rebound.

Barchart

The Highest-Rated Dividend Aristocrats to Buy-And-Hold Forever

Take a look at four of the highest-rated Dividend Aristocrats in the market right now.

StockNews.com

Becton Dickinson & Co. (BDX) Earnings Moves: A Buy or Sell for Investors?

Becton Dickinson & Co. (BDX) is expected to report steady growth for its fiscal fourth quarter ended September 2023, scheduled to be released on November 9. While the stock is witnessing weakness over the past month, will the quarterly report be able to spur a rally? Read on.

StockNews.com

3 Stocks With Decades of Dividend Payments

Concerns over high inflation, the Fed’s hawkish stance to control it, and an economic slowdown have led to immense stock market volatility. Therefore, it could be wise to invest in stocks with decades of dividend-paying history, such as Johnson & Johnson (JNJ), AbbVie (ABBV), and Becton, Dickinson and Company (BDX),…

Benzinga

What Are Whales Doing With Becton, Dickinson

Someone with a lot of money to spend has taken a bearish stance on Becton, Dickinson (NYSE:BDX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

StockNews.com

Want Passive Income? Try These 3 Dividend Stocks

Despite a decline in inflation in July, persistent concerns over a potential recession could keep the market volatile in the upcoming months. Therefore, it could be wise to invest in dividend stocks AbbVie (ABBV), Emerson Electric (EMR), and Becton Dickinson (BDX) to navigate the market volatility with solid passive income.…

Benzinga

$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,400 Today

Becton, Dickinson (NYSE:BDX) has outperformed the market over the past 10 years by 1.98% on an annualized basis producing an average annual return of 12.93%. Currently, Becton, Dickinson has a market capitalization of $70.95 billion.

1 2 3

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

359,082 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.